Suzanne Robotti, the panel's consumer representative and the executive director of DES Action USA, a group advocating for people injured by diethylstilbestrol, was the lone abstainer. "I objected to the phrasing of the question," she said. "I found the results of [the study] to be reassuring but they didn't demonstrate safety; they [just] showed no increase in harm. A range of doses was not tested with Celebrex, and I'm not confident the medical community will restrain itself when prescribing in real life."
For further related information click on the link: 10.1056/NEJMoa1611593
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd